NCT05475288View on ClinicalTrials.gov

Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer

CompletedOBSERVATIONAL
Enrollment

3,554

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Colonic NeoplasmsNeoplasm Recurrence, Local
All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT05475288 - Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer | Biotech Hunter | Biotech Hunter